Search - Université de Rennes Access content directly

Filter your results

10 Results
authFullName_s : Isabelle Rosa
Image document

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Christophe Hézode , Hélène Fontaine , Céline Dorival , Fabien Zoulim , Dominique Larrey et al.
Gastroenterology, 2014, 147 (1), pp.132-142.e4. ⟨10.1053/j.gastro.2014.03.051⟩
Journal articles inserm-01057763v1

EFFICACY AND SAFETY OF TREATMENT WITH BULEVIRTIDE IN CHRONIC HEPATITIS DELTA: PRELIMINARY RESULTS OF THE REAL LIFE ANRS HD EP01 BULEDELTA COHORT

Fabien Zoulim , Claire Fougerou , Roulot Marullo Dominique , Sophie Metivier , Victor de Ledinghen et al.
Hepatology, 2022, 76 (Supp 1), pp.S221-S223
Journal articles hal-03922586v1
Image document

Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients

Stanislas Pol , Marc Bourlière , Sandy Lucier , Christophe Hézode , Céline Dorival et al.
Journal of Hepatology, 2017, 66 (1), pp.39-47. ⟨10.1016/j.jhep.2016.08.021⟩
Journal articles hal-01435007v1
Image document

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study

Fabrice Carrat , Hélène Fontaine , Céline Dorival , Mélanie Simony , Alpha Diallo et al.
The Lancet, 2019, 393 (10179), pp.1453-1464. ⟨10.1016/S0140-6736(18)32111-1⟩
Journal articles hal-02050395v1
Image document

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

Loriane Lair-Mehiri , Carmen Stefanescu , Thibaut Vaysse , David Laharie , Xavier Roblin et al.
Digestive and Liver Disease, 2020, 52 (3), pp.268-273. ⟨10.1016/j.dld.2019.10.003⟩
Journal articles hal-03287300v1

Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.

Laurent Cotte , Joséphine Braun , Caroline Lascoux-Combe , Corine Vincent , Marc-Antoine Valantin et al.
Clinical Infectious Diseases, 2014, 59 (12), pp.1768-76. ⟨10.1093/cid/ciu659⟩
Journal articles hal-01118447v1

Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program

Christophe Hézode , Victor De Ledinghen , Hélène Fontaine , Fabien Zoulim , Pascal Lebray et al.
Hepatology, 2015, 62, pp.314A--314A. ⟨10.1002/hep.28160⟩
Journal articles hal-01380169v1
Image document

Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study

Laurent Lam , Hélène Fontaine , Marc Bourliere , Clovis Lusivika-Nzinga , Céline Dorival et al.
Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (5), pp.101713. ⟨10.1016/j.clinre.2021.101713⟩
Journal articles hal-03224103v1

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

Christophe Hézode , Hélène Fontaine , Céline Dorival , Dominique Larrey , Fabien Zoulim et al.
Journal of Hepatology, 2013, 59 (3), pp.434 - 441. ⟨10.1016/j.jhep.2013.04.035⟩
Journal articles hal-01708037v1
Image document

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Georges‐philippe Pageaux , Clovis Lusivika Nzinga , Nathalie Ganne , Didier Samuel , Céline Dorival et al.
BMC Infectious Diseases, 2022, 22 (1), pp.94. ⟨10.1186/s12879-022-07076-0⟩
Journal articles hal-03555553v1